Do analysts recommend OXBR or ZBAO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oxbridge Re 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Zhibao Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, OXBR or ZBAO?

Oxbridge Re has higher earnings, but lower revenue than Zhibao Technology. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Oxbridge Re $2.58M 3.02 -$2.08M -$0.25 N/A Zhibao Technology $38.66M 0.54 -$8.66M N/A N/A

Does the media prefer OXBR or ZBAO?

In the previous week, Oxbridge Re had 2 more articles in the media than Zhibao Technology. MarketBeat recorded 4 mentions for Oxbridge Re and 2 mentions for Zhibao Technology. Zhibao Technology's average media sentiment score of 0.94 beat Oxbridge Re's score of 0.62 indicating that Zhibao Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oxbridge Re 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Zhibao Technology 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate PRHI or OXBR?

Presurance currently has a consensus target price of $7.00, indicating a potential upside of 40.56%. Given Presurance's higher possible upside, analysts plainly believe Presurance is more favorable than Oxbridge Re. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Presurance 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Oxbridge Re 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is PRHI or OXBR more profitable?

Presurance has a net margin of -41.92% compared to Oxbridge Re's net margin of -76.47%. Oxbridge Re's return on equity of -33.33% beat Presurance's return on equity. Company Net Margins Return on Equity Return on Assets Presurance -41.92% -104.13% -8.74% Oxbridge Re -76.47% -33.33% -22.04%

Do analysts prefer OXBR or HUIZ?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oxbridge Re 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Huize 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, OXBR or HUIZ?

Huize has higher revenue and earnings than Oxbridge Re. Oxbridge Re is trading at a lower price-to-earnings ratio than Huize, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Oxbridge Re $2.58M 3.02 -$2.08M -$0.25 N/A Huize $226.26M 0.06 $580K $0.03 46.00

Is OXBR or HUIZ more profitable?

Huize has a net margin of 0.00% compared to Oxbridge Re's net margin of -76.47%. Huize's return on equity of 0.00% beat Oxbridge Re's return on equity. Company Net Margins Return on Equity Return on Assets Oxbridge Re -76.47% -33.33% -22.04% Huize N/A N/A N/A

Does the media prefer OXBR or HUIZ?

In the previous week, Oxbridge Re had 1 more articles in the media than Huize. MarketBeat recorded 4 mentions for Oxbridge Re and 3 mentions for Huize. Huize's average media sentiment score of 0.96 beat Oxbridge Re's score of 0.62 indicating that Huize is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oxbridge Re 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Huize 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate OXBR or GOCO?

GoHealth has a consensus target price of $5.00, indicating a potential upside of 1,623.54%. Given GoHealth's stronger consensus rating and higher probable upside, analysts clearly believe GoHealth is more favorable than Oxbridge Re. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oxbridge Re 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 GoHealth 1 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.20

Is OXBR or GOCO more profitable?

Oxbridge Re has a net margin of -76.47% compared to GoHealth's net margin of -189.73%. Oxbridge Re's return on equity of -33.33% beat GoHealth's return on equity. Company Net Margins Return on Equity Return on Assets Oxbridge Re -76.47% -33.33% -22.04% GoHealth -189.73% -402.70% -7.90%

Does the media refer more to OXBR or GOCO?

In the previous week, Oxbridge Re had 1 more articles in the media than GoHealth. MarketBeat recorded 4 mentions for Oxbridge Re and 3 mentions for GoHealth. GoHealth's average media sentiment score of 1.10 beat Oxbridge Re's score of 0.62 indicating that GoHealth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oxbridge Re 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive GoHealth 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate TIRX or OXBR?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tian Ruixiang 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Oxbridge Re 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, TIRX or OXBR?

Oxbridge Re has lower revenue, but higher earnings than Tian Ruixiang. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tian Ruixiang $5.86M 0.38 -$3.99M N/A N/A Oxbridge Re $2.58M 3.02 -$2.08M -$0.25 N/A

Oxbridge Re (OXBR) Competitors

$0.96 0.00 (0.00%)

Closing price 06/12/2026 04:00 PM Eastern

Extended Trading

$0.97 +0.01 (+1.25%)

As of 06/12/2026 06:16 PM Eastern

Compare

OXBR vs. ZBAO, PRHI, HUIZ, GOCO, and TIRX

Should you buy Oxbridge Re stock or one of its competitors? MarketBeat compares Oxbridge Re with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Oxbridge Re include Zhibao Technology (ZBAO), Presurance (PRHI), Huize (HUIZ), GoHealth (GOCO), and Tian Ruixiang (TIRX). These companies are all part of the "insurance" industry.

How does Oxbridge Re compare to Zhibao Technology?

Oxbridge Re (NASDAQ:OXBR) and Zhibao Technology (NASDAQ:ZBAO) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, earnings and risk.

Oxbridge Re has higher earnings, but lower revenue than Zhibao Technology.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oxbridge Re	$2.58M	3.02	-$2.08M	-$0.25	N/A
Zhibao Technology	$38.66M	0.54	-$8.66M	N/A	N/A

5.6% of Oxbridge Re shares are held by institutional investors. 16.3% of Oxbridge Re shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Oxbridge Re has a beta of 2.02, meaning that its share price is 102% more volatile than the broader market. Comparatively, Zhibao Technology has a beta of 1.13, meaning that its share price is 13% more volatile than the broader market.

Zhibao Technology has a net margin of 0.00% compared to Oxbridge Re's net margin of -76.47%. Zhibao Technology's return on equity of 0.00% beat Oxbridge Re's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oxbridge Re	-76.47%	-33.33%	-22.04%
Zhibao Technology	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oxbridge Re	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Zhibao Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Oxbridge Re had 2 more articles in the media than Zhibao Technology. MarketBeat recorded 4 mentions for Oxbridge Re and 2 mentions for Zhibao Technology. Zhibao Technology's average media sentiment score of 0.94 beat Oxbridge Re's score of 0.62 indicating that Zhibao Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Oxbridge Re	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Zhibao Technology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Oxbridge Re beats Zhibao Technology on 6 of the 11 factors compared between the two stocks.

How does Oxbridge Re compare to Presurance?

Presurance (NASDAQ:PRHI) and Oxbridge Re (NASDAQ:OXBR) are both small-cap insurance companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends.

34.9% of Presurance shares are owned by institutional investors. Comparatively, 5.6% of Oxbridge Re shares are owned by institutional investors. 73.3% of Presurance shares are owned by insiders. Comparatively, 16.3% of Oxbridge Re shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Oxbridge Re has lower revenue, but higher earnings than Presurance. Oxbridge Re is trading at a lower price-to-earnings ratio than Presurance, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Presurance	$43.30M	0.43	-$18.44M	-$9.73	N/A
Oxbridge Re	$2.58M	3.02	-$2.08M	-$0.25	N/A

Presurance currently has a consensus target price of $7.00, indicating a potential upside of 40.56%. Given Presurance's higher possible upside, analysts plainly believe Presurance is more favorable than Oxbridge Re.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Presurance	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Oxbridge Re	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Oxbridge Re had 2 more articles in the media than Presurance. MarketBeat recorded 4 mentions for Oxbridge Re and 2 mentions for Presurance. Oxbridge Re's average media sentiment score of 0.62 beat Presurance's score of 0.43 indicating that Oxbridge Re is being referred to more favorably in the news media.

Company	Overall Sentiment
Presurance	Neutral
Oxbridge Re	Positive

Presurance has a net margin of -41.92% compared to Oxbridge Re's net margin of -76.47%. Oxbridge Re's return on equity of -33.33% beat Presurance's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Presurance	-41.92%	-104.13%	-8.74%
Oxbridge Re	-76.47%	-33.33%	-22.04%

Presurance has a beta of 1.1, meaning that its stock price is 10% more volatile than the broader market. Comparatively, Oxbridge Re has a beta of 2.02, meaning that its stock price is 102% more volatile than the broader market.

Summary

Presurance and Oxbridge Re tied by winning 7 of the 14 factors compared between the two stocks.

How does Oxbridge Re compare to Huize?

Oxbridge Re (NASDAQ:OXBR) and Huize (NASDAQ:HUIZ) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oxbridge Re	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Huize	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Oxbridge Re had 1 more articles in the media than Huize. MarketBeat recorded 4 mentions for Oxbridge Re and 3 mentions for Huize. Huize's average media sentiment score of 0.96 beat Oxbridge Re's score of 0.62 indicating that Huize is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Oxbridge Re	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Huize	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

5.6% of Oxbridge Re shares are held by institutional investors. 16.3% of Oxbridge Re shares are held by company insiders. Comparatively, 30.4% of Huize shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Huize has a net margin of 0.00% compared to Oxbridge Re's net margin of -76.47%. Huize's return on equity of 0.00% beat Oxbridge Re's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oxbridge Re	-76.47%	-33.33%	-22.04%
Huize	N/A	N/A	N/A

Huize has higher revenue and earnings than Oxbridge Re. Oxbridge Re is trading at a lower price-to-earnings ratio than Huize, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oxbridge Re	$2.58M	3.02	-$2.08M	-$0.25	N/A
Huize	$226.26M	0.06	$580K	$0.03	46.00

Oxbridge Re has a beta of 2.02, indicating that its stock price is 102% more volatile than the broader market. Comparatively, Huize has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market.

Summary

Huize beats Oxbridge Re on 9 of the 13 factors compared between the two stocks.

How does Oxbridge Re compare to GoHealth?

Oxbridge Re (NASDAQ:OXBR) and GoHealth (NASDAQ:GOCO) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations and risk.

In the previous week, Oxbridge Re had 1 more articles in the media than GoHealth. MarketBeat recorded 4 mentions for Oxbridge Re and 3 mentions for GoHealth. GoHealth's average media sentiment score of 1.10 beat Oxbridge Re's score of 0.62 indicating that GoHealth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Oxbridge Re	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
GoHealth	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Oxbridge Re has higher earnings, but lower revenue than GoHealth. Oxbridge Re is trading at a lower price-to-earnings ratio than GoHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oxbridge Re	$2.58M	3.02	-$2.08M	-$0.25	N/A
GoHealth	$361.85M	0.02	-$257.13M	-$20.29	N/A

GoHealth has a consensus target price of $5.00, indicating a potential upside of 1,623.54%. Given GoHealth's stronger consensus rating and higher probable upside, analysts clearly believe GoHealth is more favorable than Oxbridge Re.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oxbridge Re	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
GoHealth	1 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.20

Oxbridge Re has a net margin of -76.47% compared to GoHealth's net margin of -189.73%. Oxbridge Re's return on equity of -33.33% beat GoHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oxbridge Re	-76.47%	-33.33%	-22.04%
GoHealth	-189.73%	-402.70%	-7.90%

5.6% of Oxbridge Re shares are held by institutional investors. Comparatively, 24.2% of GoHealth shares are held by institutional investors. 16.3% of Oxbridge Re shares are held by company insiders. Comparatively, 29.1% of GoHealth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Oxbridge Re has a beta of 2.02, suggesting that its share price is 102% more volatile than the broader market. Comparatively, GoHealth has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market.

Summary

GoHealth beats Oxbridge Re on 9 of the 16 factors compared between the two stocks.

How does Oxbridge Re compare to Tian Ruixiang?

Tian Ruixiang (NASDAQ:TIRX) and Oxbridge Re (NASDAQ:OXBR) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment.

Oxbridge Re has lower revenue, but higher earnings than Tian Ruixiang.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tian Ruixiang	$5.86M	0.38	-$3.99M	N/A	N/A
Oxbridge Re	$2.58M	3.02	-$2.08M	-$0.25	N/A

In the previous week, Oxbridge Re had 4 more articles in the media than Tian Ruixiang. MarketBeat recorded 4 mentions for Oxbridge Re and 0 mentions for Tian Ruixiang. Oxbridge Re's average media sentiment score of 0.62 beat Tian Ruixiang's score of 0.00 indicating that Oxbridge Re is being referred to more favorably in the news media.

Company	Overall Sentiment
Tian Ruixiang	Neutral
Oxbridge Re	Positive

Tian Ruixiang has a beta of 0.26, suggesting that its stock price is 74% less volatile than the broader market. Comparatively, Oxbridge Re has a beta of 2.02, suggesting that its stock price is 102% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tian Ruixiang	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Oxbridge Re	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

10.7% of Tian Ruixiang shares are owned by institutional investors. Comparatively, 5.6% of Oxbridge Re shares are owned by institutional investors. 39.6% of Tian Ruixiang shares are owned by insiders. Comparatively, 16.3% of Oxbridge Re shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Tian Ruixiang has a net margin of 0.00% compared to Oxbridge Re's net margin of -76.47%. Tian Ruixiang's return on equity of 0.00% beat Oxbridge Re's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tian Ruixiang	N/A	N/A	N/A
Oxbridge Re	-76.47%	-33.33%	-22.04%

Summary

Tian Ruixiang beats Oxbridge Re on 6 of the 11 factors compared between the two stocks.

Get Oxbridge Re News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OXBR vs. The Competition

Export

Metric	Oxbridge Re	INS Industry	Finance Sector	NASDAQ Exchange
Market Cap	$7.79M	$20.67B	$13.84B	$12.05B
Dividend Yield	N/A	1.81%	5.75%	5.66%
P/E Ratio	-3.85	20.03	20.17	24.42
Price / Sales	3.02	99.04	144.49	123.88
Price / Cash	N/A	11.36	19.50	37.92
Price / Book	1.23	2.83	2.24	6.82
Net Income	-$2.08M	$1.06B	$1.14B	$337.56M
7 Day Performance	12.58%	4.06%	1.35%	1.16%
1 Month Performance	-0.82%	5.30%	2.24%	3.16%
1 Year Performance	-37.94%	-21.38%	12.63%	30.60%

Oxbridge Re Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OXBR Oxbridge Re	0.6991 of 5 stars	$0.96 flat	N/A	-37.9%	$7.79M	$2.58M	N/A	3	Short Interest Decrease Gap Down
ZBAO Zhibao Technology	0.5131 of 5 stars	$0.65 -2.2%	N/A	-37.0%	$21.40M	$38.66M	N/A	148
PRHI Presurance	3.0671 of 5 stars	$5.05 +0.4%	$7.00 +38.6%	N/A	$18.89M	$43.30M	N/A	150	Short Interest Increase
HUIZ Huize	1.6339 of 5 stars	$1.40 +1.4%	N/A	-32.4%	$14.13M	$226.26M	46.67	1,640	News Coverage Short Interest Decrease
GOCO GoHealth	3.1668 of 5 stars	$0.29 -9.4%	$5.00 +1,624.1%	-94.9%	$8.37M	$361.85M	N/A	2,261	Positive News High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OXBR) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Oxbridge Re (OXBR) Competitors

OXBR vs. ZBAO, PRHI, HUIZ, GOCO, and TIRX

How does Oxbridge Re compare to Zhibao Technology?

Summary

How does Oxbridge Re compare to Presurance?

Summary

How does Oxbridge Re compare to Huize?

Summary

How does Oxbridge Re compare to GoHealth?

Summary

How does Oxbridge Re compare to Tian Ruixiang?

Summary

Media Sentiment Over Time

OXBR vs. The Competition

Oxbridge Re Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Oxbridge Re (OXBR) Competitors

OXBR vs. ZBAO, PRHI, HUIZ, GOCO, and TIRX

How does Oxbridge Re compare to Zhibao Technology?

Which has stronger valuation & earnings, OXBR or ZBAO?

Do institutionals and insiders believe in OXBR or ZBAO?

Which has more volatility and risk, OXBR or ZBAO?

Is OXBR or ZBAO more profitable?

Do analysts recommend OXBR or ZBAO?

Does the media prefer OXBR or ZBAO?

Summary

How does Oxbridge Re compare to Presurance?

Do institutionals and insiders have more ownership in PRHI or OXBR?

Which has stronger valuation and earnings, PRHI or OXBR?

Do analysts rate PRHI or OXBR?

Does the media refer more to PRHI or OXBR?

Is PRHI or OXBR more profitable?

Which has more volatility & risk, PRHI or OXBR?

Summary

How does Oxbridge Re compare to Huize?

Do analysts prefer OXBR or HUIZ?

Does the media prefer OXBR or HUIZ?

Do insiders and institutionals have more ownership in OXBR or HUIZ?

Is OXBR or HUIZ more profitable?

Which has better earnings & valuation, OXBR or HUIZ?

Which has more risk & volatility, OXBR or HUIZ?

Summary

How does Oxbridge Re compare to GoHealth?

Does the media refer more to OXBR or GOCO?

Which has stronger valuation & earnings, OXBR or GOCO?

Do analysts rate OXBR or GOCO?

Is OXBR or GOCO more profitable?

Do institutionals and insiders believe in OXBR or GOCO?

Which has more volatility & risk, OXBR or GOCO?

Summary

How does Oxbridge Re compare to Tian Ruixiang?

Which has stronger earnings and valuation, TIRX or OXBR?

Does the media refer more to TIRX or OXBR?

Which has more volatility and risk, TIRX or OXBR?

Do analysts rate TIRX or OXBR?

Do insiders and institutionals have more ownership in TIRX or OXBR?

Is TIRX or OXBR more profitable?

Summary

Media Sentiment Over Time

OXBR vs. The Competition

Oxbridge Re Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools